Card image cap
Phase 3 trials on Covovax as booster dose

An expert panel of India’s central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, said a notification from the office of Drug Controller General of India. The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on December 28. It is yet to be included in the country’s inoculation programme.

Content by Future Medicine

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.

Supported by Koye Pharmaceuticals

Submit a Comment